UA81493C2 - Crystal of benzimidazole derivative and process for producing the same - Google Patents

Crystal of benzimidazole derivative and process for producing the same

Info

Publication number: UA81493C2
Authority: UA; Ukraine
Prior art keywords: crystal; producing; same; benzimidazole derivative; crystals
Prior art date: 2003-05-14

Application number

UAA200511908A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-14

Filing date

2004-05-14

Publication date

2008-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33447189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA81493(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-05-14 Application filed filed Critical

2008-01-10 Publication of UA81493C2 publication Critical patent/UA81493C2/xx

Links

239000013078 crystal Substances 0.000 title abstract 3
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title abstract 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

UAA200511908A 2003-05-14 2004-05-14 Crystal of benzimidazole derivative and process for producing the same UA81493C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2003135567		2003-05-14
PCT/JP2004/006887 WO2004101551A1 (ja)	2003-05-14	2004-05-14	ベンズイミダゾール誘導体の結晶及びその製造方法

Publications (1)

Publication Number	Publication Date
UA81493C2 true UA81493C2 (en)	2008-01-10

Family

ID=33447189

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200511908A UA81493C2 (en)	2003-05-14	2004-05-14	Crystal of benzimidazole derivative and process for producing the same

Country Status (25)

Country	Link
US (1)	US7649008B2 (pt)
EP (1)	EP1626048A4 (pt)
JP (1)	JPWO2004101551A1 (pt)
KR (1)	KR20060011997A (pt)
CN (1)	CN1788007A (pt)
AR (1)	AR044340A1 (pt)
AU (1)	AU2004238708A1 (pt)
BR (1)	BRPI0410266A (pt)
CA (1)	CA2523978A1 (pt)
CL (1)	CL2004001034A1 (pt)
CO (1)	CO5660259A2 (pt)
EC (1)	ECSP056162A (pt)
IS (1)	IS8177A (pt)
MA (1)	MA27805A1 (pt)
MX (1)	MXPA05011851A (pt)
NO (1)	NO20055181L (pt)
NZ (1)	NZ542978A (pt)
PE (1)	PE20050203A1 (pt)
RU (1)	RU2332417C2 (pt)
SA (1)	SA04250117B1 (pt)
TN (1)	TNSN05288A1 (pt)
TW (1)	TW200505911A (pt)
UA (1)	UA81493C2 (pt)
WO (1)	WO2004101551A1 (pt)
ZA (1)	ZA200508640B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CL2004001034A1 (es)	2003-05-14	2005-03-28	Teijin Pharma Ltd	Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
AU2004266536A1 (en) *	2003-08-22	2005-03-03	Teijin Pharma Limited	Drug containing chymase inhibitor as the active ingredient
US20080015240A1 (en) *	2004-11-12	2008-01-17	Mitsuru Teramoto	Acid Salt of Benzimidazole Derivative and Crystal Thereof
JP2016150917A (ja) *	2015-02-17	2016-08-22	株式会社トクヤマ	バルサルタンの結晶の製造方法
JP2024521412A (ja) *	2021-06-11	2024-05-31	ジェンザイム・コーポレーション	トレブルチニブの結晶形並びにその製造方法及び使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0237608B1 (de)	1986-03-21	1992-01-29	HEUMANN PHARMA GMBH & CO	Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
US5015646A (en)	1987-08-28	1991-05-14	Bristol-Myers Squibb Co.	Pharmaceutically useful polymorphic modification of buspirone
JP3668494B2 (ja)	1994-05-31	2005-07-06	帝人株式会社	ナフタレン誘導体
ES2150353B1 (es)	1998-04-15	2001-07-01	Esteve Labor Dr	Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
HUP0103256A3 (en)	1998-07-15	2002-05-28	Teijin Ltd	Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
US20040010004A1 (en) *	2000-01-17	2004-01-15	Naoki Tsuchiya	Benzimidazole derivatives
PT1249450E (pt) *	2000-01-17	2008-01-02	Teijin Pharma Ltd	Derivados de benzimidazole como inibidores de quimase humana
NZ522150A (en) *	2001-02-22	2006-03-31	Teijin Ltd	Benzo[b]thiophene derivatives and processes for preparing the same
ATE404551T1 (de) *	2001-05-07	2008-08-15	Teijin Pharma Ltd	3-hydroxymethylbenzo b thiophen-derivate und verfahren zu deren herstellung
KR100902799B1 (ko)	2001-08-24	2009-06-12	데이진 가부시키가이샤	키마제 저해제 및 ａｃｅ 저해제를 유효성분으로 함유하는약제
CL2004001034A1 (es)	2003-05-14	2005-03-28	Teijin Pharma Ltd	Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r

2004
- 2004-05-13 CL CL200401034A patent/CL2004001034A1/es unknown
- 2004-05-14 JP JP2005506263A patent/JPWO2004101551A1/ja not_active Ceased
- 2004-05-14 MX MXPA05011851A patent/MXPA05011851A/es unknown
- 2004-05-14 PE PE2004000502A patent/PE20050203A1/es not_active Application Discontinuation
- 2004-05-14 RU RU2005138868/04A patent/RU2332417C2/ru not_active IP Right Cessation
- 2004-05-14 UA UAA200511908A patent/UA81493C2/xx unknown
- 2004-05-14 US US10/556,683 patent/US7649008B2/en not_active Expired - Fee Related
- 2004-05-14 EP EP04733128A patent/EP1626048A4/en not_active Withdrawn
- 2004-05-14 KR KR1020057021506A patent/KR20060011997A/ko not_active Ceased
- 2004-05-14 CA CA002523978A patent/CA2523978A1/en not_active Abandoned
- 2004-05-14 NZ NZ542978A patent/NZ542978A/en unknown
- 2004-05-14 AR ARP040101656A patent/AR044340A1/es unknown
- 2004-05-14 CN CNA2004800127952A patent/CN1788007A/zh active Pending
- 2004-05-14 WO PCT/JP2004/006887 patent/WO2004101551A1/ja not_active Ceased
- 2004-05-14 TW TW093113785A patent/TW200505911A/zh unknown
- 2004-05-14 BR BRPI0410266-5A patent/BRPI0410266A/pt not_active IP Right Cessation
- 2004-05-14 AU AU2004238708A patent/AU2004238708A1/en not_active Abandoned
- 2004-05-15 SA SA4250117A patent/SA04250117B1/ar unknown
2005
- 2005-10-25 ZA ZA200508640A patent/ZA200508640B/en unknown
- 2005-11-03 NO NO20055181A patent/NO20055181L/no not_active Application Discontinuation
- 2005-11-11 CO CO05115024A patent/CO5660259A2/es not_active Application Discontinuation
- 2005-11-14 EC EC2005006162A patent/ECSP056162A/es unknown
- 2005-11-14 TN TNP2005000288A patent/TNSN05288A1/en unknown
- 2005-11-14 MA MA28603A patent/MA27805A1/fr unknown
- 2005-12-13 IS IS8177A patent/IS8177A/is unknown

Also Published As

Publication number	Publication date
TW200505911A (en)	2005-02-16
NO20055181D0 (no)	2005-11-03
BRPI0410266A (pt)	2006-05-16
WO2004101551A1 (ja)	2004-11-25
NO20055181L (no)	2006-01-24
JPWO2004101551A1 (ja)	2006-07-13
KR20060011997A (ko)	2006-02-06
MA27805A1 (fr)	2006-03-01
US7649008B2 (en)	2010-01-19
CL2004001034A1 (es)	2005-03-28
PE20050203A1 (es)	2005-03-26
ECSP056162A (es)	2006-04-19
CN1788007A (zh)	2006-06-14
MXPA05011851A (es)	2006-02-17
IS8177A (is)	2005-12-13
RU2005138868A (ru)	2006-07-10
NZ542978A (en)	2009-04-30
AR044340A1 (es)	2005-09-07
EP1626048A4 (en)	2008-11-12
SA04250117B1 (ar)	2009-09-02
EP1626048A1 (en)	2006-02-15
CO5660259A2 (es)	2006-07-31
ZA200508640B (en)	2007-02-28
AU2004238708A1 (en)	2004-11-25
RU2332417C2 (ru)	2008-08-27
TNSN05288A1 (en)	2007-07-10
US20060293375A1 (en)	2006-12-28
CA2523978A1 (en)	2004-11-25

Publication	Publication Date	Title
NO20071617L (no)	2007-04-20	Indozolonderivater som 11B-HSD1-inhibitorer
NZ592897A (en)	2012-12-21	Crystals of laquinimod sodium, and process for the manufacture thereof
JO2282B1 (en)	2005-09-12	Oxazole derivatives
JO2353B1 (en)	2006-12-12	New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
MX2007010532A (es)	2007-10-12	Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
IS8230A (is)	2006-01-12	Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
NO20083708L (no)	2008-09-23	4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
GB0314967D0 (en)	2003-07-30	Piperazine derivatives
IL183636A0 (en)	2007-09-20	Quinoline derivative, use and production thereof, and drug containing the same
DK1513800T3 (da)	2007-03-26	Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
WO2003006443A3 (de)	2003-05-01	2-`4-(naphtalin-2yl)-thiazol-2-ylaminocarbonyl benzoesäure und 2-`4-(naphtalin-2yl)-pyrimidin-2-ylaminocarbonyl benzoesäure und andere verbindungen als telomerase-hemmer zur anwendung in der tumortherapie
SE0302756D0 (sv)	2003-10-17	Novel Compounds
MY138698A (en)	2009-07-31	Method for synthesis of (2s)-indoline-2-carboxylic acid, and use in the synthesis of perindopril
IL166057A0 (en)	2006-01-15	Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
MY138550A (en)	2009-06-30	Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139228A (en)	2009-08-28	Imidazolinylmethyl aralkylsulfonamides
TNSN05288A1 (en)	2007-07-10	Crystal of benzimidazole derivative and process for producing the same
MY136938A (en)	2008-11-28	New process for the synthesis of perindopril and its pharmaceutically acceptable salts
TW200621703A (en)	2006-07-01	Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MY136288A (en)	2008-09-30	New process for the synthesis of perindopril and its pharmaceutically acceptable salts
AU2003237595A1 (en)	2004-12-13	Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
AU2002247949A1 (en)	2003-10-13	Process for synthesis of trans-alkenoic acid, use thereof
TN2009000069A1 (en)	2010-08-19	Polymorph of (r) -3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azoni a-bicylco-[2.2.2]octane bromide
MY139098A (en)	2009-08-28	Method for synthesis of perindopril and its pharmaceutically acceptable salts
NO20060922L (no)	2006-02-24	Ny fremgangsmate for syntesen av perindopril og dens farmasoytiske akseptable salter